Skip to main content
  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

AACR logo

  • Register
  • Log in
  • My Cart
Advertisement

Main menu

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Rapid Impact Archive
    • Meeting Abstracts
    • Collections
      • COVID-19 & Cancer Resource Center
      • Metabolism Collection
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Spotlight on Genomic Analysis of Rare and Understudied Cancers
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

User menu

  • Register
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Cancer Research
Molecular Cancer Research
  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Rapid Impact Archive
    • Meeting Abstracts
    • Collections
      • COVID-19 & Cancer Resource Center
      • Metabolism Collection
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Spotlight on Genomic Analysis of Rare and Understudied Cancers
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

Highlights

Highlights of This Issue

DOI:  Published March 2018
  • Article
  • Info & Metrics
  • PDF
Loading

Characterization of a Well-differentiated Human NET Model

Benten et al. Page 496

Research on new therapies for pancreatic neuroendocrine tumors (pNET) has been hampered by the absence of a clinically relevant tumor model system. Benten and colleagues now provide data on the first well-differentiated and slow-growing human pNET cell line, which is stable and functionally active over many passages. The pNET cell line is also capable of creating a corresponding xenograft model where resulting subcutaneous and intrahepatic tumors resemble the human pNET tumor of origin. Absence of p53 and Ras mutations as well as high expression of somatostatin receptors make this cell line clinically relevant among available pNET cell lines.

Blocking p27 Phosphorylation Potently Arrests Cell Cycle

Patel et al. Page 361

Cyclin-dependent kinase 4/6 (CDK4/6) inhibitors, such as palbociclib, have shown clinical efficacy, but resistance has emerged as a significant problem. This study demonstrates that CDK2 compensates for loss of CDK4 activity to rescue palbociclib-arrested breast cancer cells, suggesting that inhibition of both kinases is required to achieve durable response. A novel strategy is described to inhibit tyrosine phosphorylation of the cyclin-CDK4 assembly factor, p27Kip1 (CDKN1B). Modulating tyrosine phosphorylation of p27 inhibits both proliferative (CDK4) and resistance (CDK2) mechanisms in breast cancer and suggests a role for phospho-p27 as a biomarker for patients that are responsive to CDK4/6 inhibition.

14q32 miRNA Cluster Induces Metastasis in Lung Cancer

González-Vallinas et al. Page 390

Metastasis is responsible for most lung cancer deaths; however, the molecular mechanism of tumor cell dissemination is not completely understood. Here, González-Vallinas and colleagues demonstrate overexpression of the chromosome 14q32 miRNA cluster in lung adenocarcinoma patients and its association with genomic DNA hypomethylation using different epigenetic analyses. Simultaneous overexpression of chromosome 14q32 cluster miRNAs, by CRISPR activation technology, revealed that these miRNAs promote cell migration and invasion. Among them, miR-323b, miR-487a and miR-539 strongly contribute to these phenotypes and associate with patient disease-free survival. Thus, chromosome 14q32 cluster miRNAs represent promising anti-tumor targets and prognostic biomarkers in lung adenocarcinoma metastasis.

Metabolism Regulation via BRCA1-Destabilized Oct1

Vázquez-Arreguín et al. Page 439

BRCA1 is a prominent tumor suppressor with roles in DNA damage response (DDR) and other incompletely defined functions. In conjunction with another protein, BARD1, BRCA1 has an enzymatic E3 ubiquitin ligase activity. Vázquez-Arreguín and colleagues report that cells lacking this activity have a cancer-associated glycolytic metabolic profile. A new ubiquitination target of BRCA1 was identified, the transcription factor Oct1, and shown to control metabolism downstream of BRCA1. In primary human breast cancer specimens, Oct1 inversely correlates with BRCA1 protein levels and positively correlates with tumor grade. Thus, this study highlights the importance of other activities of BRCA1 apart from DNA repair.

  • ©2018 American Association for Cancer Research.
PreviousNext
Back to top
Molecular Cancer Research: 16 (3)
March 2018
Volume 16, Issue 3
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Editorial Board (PDF)

Sign up for alerts

View this article with LENS

Open full page PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Molecular Cancer Research article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Highlights of This Issue
(Your Name) has forwarded a page to you from Molecular Cancer Research
(Your Name) thought you would be interested in this article in Molecular Cancer Research.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Highlights of This Issue
Mol Cancer Res March 1 2018 (16) (3) 359;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Highlights of This Issue
Mol Cancer Res March 1 2018 (16) (3) 359;
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Characterization of a Well-differentiated Human NET Model
    • Blocking p27 Phosphorylation Potently Arrests Cell Cycle
    • 14q32 miRNA Cluster Induces Metastasis in Lung Cancer
    • Metabolism Regulation via BRCA1-Destabilized Oct1
  • Info & Metrics
  • PDF
Advertisement

Related Articles

Cited By...

More in this TOC Section

  • Selected Articles from This Issue
  • Selected Articles from This Issue
  • Selected Articles from This Issue
Show more Highlights
  • Home
  • Alerts
  • Feedback
  • Privacy Policy
Facebook  Twitter  LinkedIn  YouTube  RSS

Articles

  • Online First
  • Current Issue
  • Past Issues
  • Rapid Impact Archive
  • Meeting Abstracts

Information for

  • Authors
  • Subscribers
  • Advertisers
  • Librarians

About MCR

  • About the Journal
  • Editorial Board
  • Permissions
  • Submit a Manuscript
AACR logo

Copyright © 2021 by the American Association for Cancer Research.

Molecular Cancer Research
eISSN: 1557-3125
ISSN: 1541-7786

Advertisement